Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “neurofibromatosis1 (NF1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02944032
What this trial is testing

Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
Kristina Hardy 103
Not applicableLooking for participantsNCT05954416
What this trial is testing

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Who this might be right for
Inherited Epidermolysis BullosaIchthyosisEctodermal Dysplasia+6 more
Institut National de la Santé Et de la Recherche Médicale, France 900
Early research (Phase 1)Enrolling By InvitationNCT06300502
What this trial is testing

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Who this might be right for
Neurofibromas, CutaneousNeurofibromatosis 1
Massachusetts General Hospital 15
Not applicableLooking for participantsNCT06360406
What this trial is testing

Real-World Treatment Study of Koselugo (Selumetinib)

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
AstraZeneca 200
Not applicableActive Not RecruitingNCT05388370
What this trial is testing

PASS of Paediatric Patients Initiating Selumetinib

Who this might be right for
Neurofibromatosis Type 1
AstraZeneca 124
Not applicableStudy completedNCT04879160
What this trial is testing

Systematically Assessing Changes in Plexiform Neurofibroma Related Disfigurement From Photographs of Subjects With Neurofibromatosis Type 1 on a Phase 2 Clinical Trial

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 52
Not applicableLooking for participantsNCT06507748
What this trial is testing

Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1
National Cancer Institute (NCI) 70
Not applicableUnknownNCT04856514
What this trial is testing

Open Trial of Telehealth Group for Improving Peer Relationships (PEERS) in NF1

Who this might be right for
Neurofibromatosis 1Social Skills
University of Wisconsin, Milwaukee 8
Not applicableLooking for participantsNCT04763109
What this trial is testing

Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence

Who this might be right for
Neurofibromatosis Type 1
Nicole Baca 15
Not applicableStudy completedNCT04991428
What this trial is testing

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
University of Manchester 31
Testing effectiveness (Phase 2)Study completedNCT03326388
What this trial is testing

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaOptic Nerve Glioma
Great Ormond Street Hospital for Children NHS Foundation Trust 14
Not applicableStudy completedNCT05912400
What this trial is testing

Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
University of Arkansas 55
Not applicableActive Not RecruitingNCT03820778
What this trial is testing

Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1

Who this might be right for
Neurofibromatosis 1NeurofibromaAtypical Neurofibroma+3 more
Children's National Research Institute 10
Not applicableUnknownNCT06379230
What this trial is testing

A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE)

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 2,000
Early research (Phase 1)Study completedNCT01031901
What this trial is testing

Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

Who this might be right for
Tuberous SclerosisNeurofibromatosesAngiofibroma+1 more
The University of Texas Health Science Center, Houston 52
Not applicableStudy completedNCT01445314
What this trial is testing

Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

Who this might be right for
HIVBrain TumorsNeurofibromatosis Type 1
National Cancer Institute (NCI) 598
Not applicableEnrolling By InvitationNCT06515860
What this trial is testing

Neurofibromatosis Type 1 Tumor Early Detection Study

Who this might be right for
Neurofibromatosis Type 1Neurofibromatosis 1Plexiform Neurofibroma+4 more
David Miller 1,000
Not applicableStudy completedNCT04153344
What this trial is testing

Function of the Pigment Epithelium in Patients With Type 1 Neurofibromatosis

Who this might be right for
Neurofibromatosis Type 1
Assistance Publique - Hôpitaux de Paris 30
Testing effectiveness (Phase 2)Study completedNCT04435665
What this trial is testing

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

Who this might be right for
Neurofibromatosis 1Cutaneous Neurofibroma
NFlection Therapeutics, Inc. 48
Not applicableStudy completedNCT01707836
What this trial is testing

Neurofibromatosis Type 1 Brain Tumor Genetic Risk

Who this might be right for
Neurofibromatosis Type 1Pediatric Brain Tumor
Washington University School of Medicine 176
Next Page